Ceftazidime-Avibactam Treatment for Carbapenemase-Producing Enterobacterales in a South African Children’s Hospital
- 30 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 13 (10) , 541-546
Abstract
This study describes ceftazidime-avibactam use in 17 young children from a resource-constrained country, where intra-abdominal infection was common. All-cause mortality was 53%. Earlier initiation, dose optimization, recording infusion times, and reviewing the need for additional antibiotics were identified as easy-to-implement-antimicrobial-stewardship interventions.Keywords
This publication has 11 references indexed in Scilit:
- Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective StudyInfection and Drug Resistance, 2023
- Ceftolozane/Tazobactam and Ceftazidime/Avibactam: An Italian Multi-center Retrospective Analysis of Safety and Efficacy in Children With Hematologic Malignancies and Multi-drug Resistant Gram-negative Bacteria InfectionsThe Pediatric Infectious Disease Journal, 2022
- Ceftazidime-Avibactam as Salvage Treatment for Infections Due to Carbapenem-Resistant Klebsiella pneumoniae in Liver Transplantation RecipientsInfection and Drug Resistance, 2021
- Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-AnalysisAntibiotics, 2020
- Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing EnterobacteralesClinical Infectious Diseases, 2020
- Carbapenem-Resistant Gram-Negative Bacterial Infections in ChildrenAntimicrobial Agents and Chemotherapy, 2020
- Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial InfectionsOpen Forum Infectious Diseases, 2019
- Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of AgeThe Pediatric Infectious Disease Journal, 2019
- Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case seriesSouth African Medical Journal, 2016
- Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infectionsJournal of Antimicrobial Chemotherapy, 2016